🇺🇸 FDA
Patent

US 7704985

Treatment of irritable bowel syndrome and related bowel diseases

granted A61KA61K31/57A61P

Quick answer

US patent 7704985 (Treatment of irritable bowel syndrome and related bowel diseases) held by The Board of Regents of the University of Texas System expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/57, A61P, A61P1/00